Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence-Reference-Cited by-同舟云学术

Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence

Published:2017-04-06 Issue:7 Volume:8 Page:1589-1597
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Kumar Baldeep¹^ORCID,Modi Manish²,Saikia Biman³,Medhi Bikash¹^ORCID

Affiliation:

1. Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India

2. Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India

3. Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India

Funder

Indian Council of Medical Research

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00084

Reference25 articles.

1. ILAE Official Report: A practical clinical definition of epilepsy

2. Applicability of microdialysis as a technique for pharmacokinetic–pharmacodynamic (PK–PD) modeling of antihypertensive beta-blockers

3. Enhanced Brain Delivery of Dimethyl Fumarate Employing Tocopherol-Acetate-Based Nanolipidic Carriers: Evidence from Pharmacokinetic, Biodistribution, and Cellular Uptake Studies

4. Lacosamide for the prevention of partial onset seizures in epileptic adults

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is intranasal administration an opportunity for direct brain delivery of lacosamide?;European Journal of Pharmaceutical Sciences;2021-02

2. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration;International Journal of Pharmaceutics;2021-01

3. Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer’s disease;Bioorganic Chemistry;2019-09

4. The Impact of Prophylactic Lacosamide on LPS-Induced Neuroinflammation in Aged Rats;Inflammation;2019-07-02

5. Lacosamide in bipolar disorder: A 30-day comparison to a retrospective control group treated with other antiepileptics;Psychiatry and Clinical Neurosciences;2018-10-19